Systemic sclerosis: a prototypic multisystem fibrotic disorder. - Wikidata - wikimedia - TriplyDB

Systemic sclerosis: a prototypic multisystem fibrotic disorder.

Systemic sclerosis: a prototypic multisystem fibrotic disorder.

http://www.wikidata.org/entity/Q35649427

about

Genome-wide scan identifies TNIP1, PSORS1C1, and RHOB as novel risk loci for systemic sclerosis alpha2-antiplasmin is associated with the progression of fibrosis Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling Cellular and molecular mechanisms of fibrosis Current perspectives on the immunopathogenesis of systemic sclerosis Endothelial to Mesenchymal Transition (EndoMT) in the Pathogenesis of Human Fibrotic Diseases Recent Treatments of Interstitial Lung Disease with Systemic Sclerosis MicroRNAs Regulating Signaling Pathways: Potential Biomarkers in Systemic Sclerosis Roles of Proteoglycans and Glycosaminoglycans in Wound Healing and Fibrosis Genetics of systemic sclerosis: recent advances Optical coherence tomography (OCT) of collagen in normal skin and skin fibrosis Recent developments in myofibroblast biology: paradigms for connective tissue remodeling MMP-12 deficiency attenuates angiotensin II-induced vascular injury, M2 macrophage accumulation, and skin and heart fibrosis Oxidative stress in cancer and fibrosis: Opportunity for therapeutic intervention with antioxidant compounds, enzymes, and nanoparticles αv integrins: key regulators of tissue fibrosis Recent advances in the genetics of systemic sclerosis: toward biological and clinical significance Animal models of systemic sclerosis: their utility and limitations.Oxidative damage and antioxidative therapy in systemic sclerosis Molecular targets for therapy in systemic sclerosis Regulatory mechanisms of anthrax toxin receptor 1-dependent vascular and connective tissue homeostasis Global gene expression profiling in PAI-1 knockout murine heart and kidney: molecular basis of cardiac-selective fibrosis Intrinsic Deregulation of Vascular Smooth Muscle and Myofibroblast Differentiation in Mesenchymal Stromal Cells from Patients with Systemic Sclerosis Downregulation of TGF-β Receptor-2 Expression and Signaling through Inhibition of Na/K-ATPase Proinflammatory effects of diesel exhaust nanoparticles on scleroderma skin cells Differentiation potential of CD14+ monocytes into myofibroblasts in patients with systemic sclerosis Cellular mechanisms of tissue fibrosis. 1. Common and organ-specific mechanisms associated with tissue fibrosis.Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer.Serum VEGF levels are related to the presence of pulmonary arterial hypertension in systemic sclerosis.Rac inhibition reverses the phenotype of fibrotic fibroblasts The transcriptional cofactor nab2 is induced by tgf-Beta and suppresses fibroblast activation: physiological roles and impaired expression in scleroderma.A non-Smad mechanism of fibroblast activation by transforming growth factor-beta via c-Abl and Egr-1: selective modulation by imatinib mesylate.Targeting the myofibroblast genetic switch: inhibitors of myocardin-related transcription factor/serum response factor-regulated gene transcription prevent fibrosis in a murine model of skin injury.A synthetic PPAR-γ agonist triterpenoid ameliorates experimental fibrosis: PPAR-γ-independent suppression of fibrotic responses Proteomic analysis identification of a pattern of shared alterations in the secretome of dermal fibroblasts from systemic sclerosis and nephrogenic systemic fibrosis.Lymphatic and blood vessels in scleroderma skin, a morphometric analysis.PPARγ downregulation by TGFß in fibroblast and impaired expression and function in systemic sclerosis: a novel mechanism for progressive fibrogenesis Angiotensin receptor type 1 and endothelin receptor type A on immune cells mediate migration and the expression of IL-8 and CCL18 when stimulated by autoantibodies from systemic sclerosis patients Serum protein profiling of systemic lupus erythematosus and systemic sclerosis using recombinant antibody microarrays STAT4 is a genetic risk factor for systemic sclerosis in a Chinese population.Perceived functioning has ethnic-specific associations in systemic sclerosis: another dimension of personalized medicine

P2860

Q21144954-41DB392E-2966-4416-BD55-61989524AB3F Q22001525-C7162915-114B-42AB-95F2-F658D9ECA3CD Q24647357-32E6DE96-329A-4D09-AF55-AF77BA8430B0 Q24648892-373CF378-8D88-43DD-973B-B55258080681 Q26741264-05E0FFBE-569A-4ADC-91D2-6DFE129208DD Q26748338-1F7319AD-E4A5-4FD9-86F6-E55CF5C1F932 Q26773161-922DDA21-E669-4CE8-9189-7690CED3D21C Q26781257-FDD4E9F3-9CD4-43DB-B9BD-2A691F9623E9 Q26786042-6B7C0630-1B65-448F-B263-BEDF5A714E96 Q26796362-42E7A7C9-5877-4B35-9F95-7CEEE14EDC49 Q26823616-84387BC8-CF5F-40A8-A959-92D5A0F8DB0C Q26863751-D1CBCB51-9655-4582-9125-433921CC7DC2 Q27339129-DF73EEDF-A808-430F-8F2E-7F3590F3D021 Q28075551-1344E9C5-DB62-45DE-A682-098FBAABD5E9 Q28076205-496E3613-E2EB-47DD-BF4B-0AF975A742DE Q28088499-CAE2AB85-E6A0-4D43-9EDE-78E71EEC1A73 Q28390528-C66E54A0-E8B8-45E5-9CA0-221147C1C28D Q28394733-439C199C-E023-468A-A282-74CDEF0A54B1 Q28484123-FD7F24B0-3292-415C-8E48-43405CB3EB75 Q28504689-DA22A567-D4F7-40CF-9C5F-5ADFDB0CDF64 Q28533371-7AECBBB8-237F-47BB-AF93-835ECC1D6378 Q28551230-B5347454-44BA-469E-8362-87ACB1C11321 Q28555194-63ADD5A5-8F0D-4790-99B4-6540C2990966 Q28658168-162FFD4C-848D-4EDA-9DC5-EA7B3812A6EB Q28731304-3D490D29-2B7F-4BB2-9B04-3A578C057EDB Q30443462-9208673D-630A-468A-963B-FBC4611F8B88 Q30476541-26DAAA18-DB98-4502-BAA3-678711E4F576 Q33442068-DB3DC0A5-ECEE-436E-8A2E-D9C5FFED130B Q33510140-F30828D0-9786-44A8-91A4-9346E1906E92 Q33514874-BFA78219-C8BC-4717-A78D-2651B2B73BEC Q33551475-415F6F1A-CC2C-45B1-B5D9-B9413A0B0148 Q33603627-AB917D32-9775-48B8-A4CF-4216D3AA03D1 Q33637862-CE3FFCDF-197D-4EE7-B46F-FE83BAA8841F Q33665990-C9A0849D-2890-4B0E-81F8-8807DA370904 Q33690441-1FF1C2FC-B148-4C95-BBB0-30FA51C00D55 Q33745028-2743765F-3B10-4B5C-8B7B-9F99D862808E Q33765684-A0E9949A-E8EC-4F2B-930C-16591E0E38FC Q33829507-669DB8FC-0528-4FC7-8E16-48CEB3CDEF19 Q33929738-D16E2741-938E-4DFA-ABBC-469B858C73F5 Q33945954-B1A4DD85-806E-4183-ADE6-05989E705F17

P2860

Systemic sclerosis: a prototypic multisystem fibrotic disorder.

http://www.wikidata.org/entity/Q35649427

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Systemic sclerosis: a prototypic multisystem fibrotic disorder.

@ast

Systemic sclerosis: a prototypic multisystem fibrotic disorder.

@en

type

label

Systemic sclerosis: a prototypic multisystem fibrotic disorder.

@ast

Systemic sclerosis: a prototypic multisystem fibrotic disorder.

@en

prefLabel

Systemic sclerosis: a prototypic multisystem fibrotic disorder.

@ast

Systemic sclerosis: a prototypic multisystem fibrotic disorder.

@en

P1433

Q35649427-930B0580-9F9D-48AD-AAE7-C92E1C393C69

P1476

Q35649427-B0168B4F-997E-4214-92A5-E43DDA017AC3

P2093

Q35649427-8F2D9A43-89DF-497E-BA4F-54C0FC8E7B74

Q35649427-B4C877FB-7F97-4C1A-ACCD-5A3B344644AA

P2860

Q35649427-0FAA2853-F7F5-45CF-A4B5-A2D2FF314681

Q35649427-10D2E064-2A1B-4590-B0E9-8F2107111966

Q35649427-156B4BEA-A257-4F47-AFA4-CF5659634925

Q35649427-1B647817-E5EA-41B8-A499-4779714DC62B

Q35649427-1BA95842-AE1A-4F34-9411-F32F6EF144F1

Q35649427-23EF3DB9-9FC5-42CE-94C3-C333E4A38524

Q35649427-2BE7F2E5-CF03-46B5-A00B-445B15697918

Q35649427-2D49BBF3-990C-48CE-8B71-958F209BFA59

Q35649427-2D58A3EF-1489-4905-83ED-5510D93E5C49

Q35649427-2DE4ABE8-F290-4E3A-9B4A-1581B6876304

P304

Q35649427-27FF6717-A683-4BD5-A176-B6CC9ACEA90A

P31

Q35649427-52905AF0-31FC-44B3-BEA9-8D4B33B94D70

P356

Q35649427-9A4BA5CD-41A2-40CD-B364-8A489BDDC825

P407

Q35649427-0CFA2997-5652-4DC3-930B-FEBD62420531

P433

Q35649427-219AB54B-303A-4939-B3CE-309E73504D87

P478

Q35649427-C167833B-884A-434C-94C7-6F9D3D773394

P577

Q35649427-B3A7EFBD-808B-4400-9522-DBE7B0B6E20E

P698

Q35649427-1908AA10-2945-4F61-9709-E626BF7AF70E

P932

Q35649427-857838E4-ECE6-4FB4-B11C-D968F808F889

P356

P1433

Journal of Clinical Investigation

P1476

Systemic sclerosis: a prototypic multisystem fibrotic disorder.

@en

P2093

David Abraham

http://www.w3.org/2001/XMLSchema#string

John Varga

http://www.w3.org/2001/XMLSchema#string

P2860

Epithelial-mesenchymal transition and its implications for fibrosis

Latent transforming growth factor beta-binding protein 1 interacts with fibrillin and is a microfibril-associated protein

Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome

Shared expression of phenotypic markers in systemic sclerosis indicates a convergence of pericytes and fibroblasts to a myofibroblast lineage in fibrosis

Antibodies against human cytomegalovirus in the pathogenesis of systemic sclerosis: a gene array approach

Role of transforming growth factor beta in human disease

Making sense of latent TGFbeta activation

All in the CCN family: essential matricellular signaling modulators emerge from the bunker

Systemic sclerosis immunoglobulin G autoantibodies bind the human cytomegalovirus late protein UL94 and induce apoptosis in human endothelial cells.

Human cytomegalovirus and the vasculopathies of autoimmune diseases (especially scleroderma), allograft rejection, and coronary restenosis.

P304

557-567

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI31139

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

117

http://www.w3.org/2001/XMLSchema#string

P577

2007-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17332883

http://www.w3.org/2001/XMLSchema#string

P932

1804347

http://www.w3.org/2001/XMLSchema#string